生物活性材料(英文)(Bioactive Materials)

生物活性材料(英文)(Bioactive Materials) 知网目次维普目次

  • CSCD
  • 高T1
基本信息
  • 主管单位:

    中国科学院

  • 主办单位:

    中国科技出版传媒股份有限公司

  • 国际刊号:

    2097-1192;EISSN 2452-199X

  • 国内刊号:

    10-1775/Q

  • 学科分类:

    生物科学

  • 字数:

    22000-36000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-月刊

  • 特殊属性:

联系信息
  • 电话:

  • 邮箱:

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网目次,维普目次

  • 级别:

    CSCD,高T1

期刊简介

《生物活性材料(英文)(Bioactive Materials)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、官网网址:

http://www.keaipublishing.com/en/journals/bioactive-materials/

https://www.sciencedirect.com/journal/bioactive-materials

3、投稿系统:

https://www.editorialmanager.com/bioactmat

4、出刊日期:月刊,每月出版1期。

2023年8月10日星期四

《生物活性材料(英文)》作者指南

【官网信息】

Guide for Authors

INTRODUCTION

Types of article

Original Research: Provide a full length account of original research.

Review: Provide an in-depth and up to date critical review of a related topic.

Leading

Opinion Paper: Opinionated exposition on an important scientific issue

or event designed to stimulate further discussion in a broader

scientific forum. This article type may only be submitted by invitation

from the Editor-in-Chief.

When

submitting opinion paper, please ensure to add the words “Opinion

paper” before the article title. Example: Opinion paper: Photo-curing

.... challenges.

Contact details for submission

The

peer review submission system for Bioactive Materials is located here:

https://www.editorialmanager.com/bioactmat/default.aspx

Submission checklist

You

can use this list to carry out a final check of your submission before

you send it to the journal for review. Please check the relevant section

in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

o E-mail address o Full postal address

All necessary files have been uploaded:

Manuscript:

o Include keywords

o All figures (include relevant captions)

o All tables (including titles, description, footnotes)

o Ensure all figure and table citations in the text match the files provided

o Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

o Manuscript has been 'spell checked' and 'grammar checked'

o All references mentioned in the Reference List are cited in the text, and vice versa

o Permission has been obtained for use of copyrighted material from other sources (including the Internet)

o A competing interests statement is provided, even if the authors have no competing interests to declare

o Journal policies detailed in this guide have been reviewed

o Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

Submission checklist

You

can use this list to carry out a final check of your submission before

you send it to the journal for review. Please check the relevant section

in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

BEFORE YOU BEGIN

Ethics in publishing

Please see our information on Ethics in publishing.

Informed Consent:

If

your manuscript is related to clinical study, please provide following

pieces of information and state them in your manuscript: 1) date of IRB

approval and the approval number, 2) status of informed consent (IC);

[e.g. Was written IC required? Was your clinical study approved without

IC? If so, the reason why?]

I

confirm that I have obtained all consents required by applicable law

for the publication of any personal details or images of patients,

research subjects or other individuals that are used in the materials

submitted to KeAi. I have retained a written copy of all such consents

and I agree to provide KeAi with copies of the consents or evidence that

such consents have been obtained if requested by KeAi.

Clinical research must include IRB approval and patient consent forms.

Animal Experiments:

Does

your research involve experimentation on animals? If so, please provide

name of the ethical committee approving these experiments and confirm

authors' compliance with all relevant ethical regulations.

Human subjects:

Does

your study include human subjects? If so, please provide name of the

ethical committee approving these experiments, confirm authors'

compliance with all relevant ethical regulations, and confirm that

written consent has been obtained from all patients.

……

更多详情:

http://www.keaipublishing.com/en/journals/bioactive-materials/guide-for-authors/

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。